Vasculitis - Vaskulitishttps://en.wikipedia.org/wiki/Vasculitis
Vaskulitis (Vasculitis) bụ otu nsogbu na-emebi arịa ọbara site na mbufụt. Enwere ike ịhazi Vasculitis site na ihe kpatara ya, ebe ọ dị, ụdị ụgbọ mmiri ma ọ bụ nha nke arịa. Enwere ike ịchọ nyocha ụlọ nyocha na biopsy akpụkpọ ahụ iji chọpụta ihe kpatara ya. A na-eduzi ọgwụgwọ n'ozuzu n'ịkwụsị mbufụt na igbochi usoro ahụ ji alụso ọrịa ọgụ. Dịka ọmụmaatụ, a na-eji corticosteroids dị ka prednisone.

Nchọpụta
Vasculitis na-ejedebe na akpụkpọ ahụ nwere ike imewanyewanye ka oge na-aga. Agbanyeghị, enwere ike ime nyocha ọbara na mmamịrị iji chọpụta nsogbu sistemu ma ọ bụ autoimmune.

Ọgwụgwọ - Ọgwụ OTC
Ọ bụrụ na vasculitis na-ejedebe na akpụkpọ ahụ na-enweghị mwakpo nke akụkụ ndị ọzọ, enwere ike iji ude steroid.
#OTC steroid ointment
☆ Na nsonaazụ Stiftung Warentest nke 2022 sitere na Germany, afọ ojuju ndị ahịa na ModelDerm dị ntakịrị ntakịrị karịa na nyocha telemedicine akwụ ụgwọ.
  • Ekwesịrị iwepụ nsogbu sistemu ndị ọzọ (ọrịa autoimmune) metụtara vasculitis.
  • Nke a bụ foto a na-ahụkarị nke vasculitis nke ụkwụ. Enwere ike ime nyocha mmamịrị iji chọpụta ihe adịghị mma na ọrụ akụrụ.
  • Livedo vadculopathy
  • Purpura
  • Henoch schonlein purpura
References An aetiological & clinicopathological study on cutaneous vasculitis 22382191 
NIH
Of the 61 patients studied, hypersensitivity vasculitis (HSV) [23 (37.7%)] and Henoch Schonlein purpura (HSP) [16 (26.2%)] were the two most common forms. Systemic involvement was seen in 32 (52.45%) patients. Drugs were implicated in 12 (19.7%) cases, infections in 7 (11.4%) and connective tissue disorders in 4 (6.5%) cases. No association was seen between history of drug intake and tissue eosinophilia and also between histologically severe vasculitis and clinical severity.
 Leukocytoclastic Vasculitis 29489227 
NIH
Leukocytoclastic vasculitis bụ ụdị mbufụt nke anụ ahụ na-emetụta obere arịa ọbara n'ime oghere dị omimi nke akpụkpọ ahụ. Ọ nwere ike ime n'amaghị ihe kpatara ya ma ọ bụ jikọta ya na ọrịa, etuto ahụ, ọrịa autoimmune, ma ọ bụ ọgwụ. Ihe ịrịba ama na-agụnye ntụpọ uhie ma ọ bụ odo odo na ụkwụ, itinye aka nke obere arịa, na ihe dị ka pasent 30 nke ikpe, akụkụ ahụ ndị ọzọ na-emetụtakwa. Ọtụtụ ikpe na-ekpochapụ onwe ha n'ime izu ole na ole ruo ọnwa. Ọgwụgwọ dịgasị iche dabere n'otú ọ siri sie ike, site na iji nwayọọ nwayọọ na-ebelata ọnụ corticosteroids ruo iji ọgwụ ndị ọzọ na-ebelata mbufụt na-enweghị steroid.
Leukocytoclastic vasculitis is a cutaneous, small-vessel vasculitis of the dermal capillaries and venules. This condition can be idiopathic or can be associated with infections, neoplasms, autoimmune disorders, and drugs. Key clinical features of leukocytoclastic vasculitis include palpable purpura on the lower extremity, small vessel involvement, and, in about 30 percent of individuals, extracutaneous involvement. Most cases of idiopathic cutaneous, small vessel vasculitis are self-limited with 90 percent of cases resolving in weeks to months of onset. Otherwise, treatment depends on the severity of disease and can range from an oral corticosteroid taper to various steroid-sparing immunosuppressive agents.